Arrigo F G Cicero

Summary

Country: Italy

Publications

  1. ncbi Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study
    Arrigo F G Cicero
    Department of Internal Medicine and Applied Biotechnology, Atherosclerosis and Metabolic Diseases Study Centre G Descovich, University of Bologna, S Orsola Malpighi University Hospital Via Massarenti, 9 40138 Bologna, Italy
    Complement Ther Med 13:273-8. 2005
  2. ncbi Effect of oral chronic isoflavones supplementation on male rat sexual performances and sexual hormone plasma levels
    Arrigo F G Cicero
    Biomedical Sciences Department, Pharmacology Section, University of Modena and Reggio nell emilia, Modena, Italy
    Phytother Res 18:849-52. 2004
  3. ncbi Asymptomatic massive hypertriglyceridemia in an octogenarian
    Arrigo F G Cicero
    Atherosclerosis and Metabolism Diseases Study Centre GC Descovich, Clinical Medicine and Applied Biotechnology Department D Campanacci, University of Bologna, Italy
    Med Princ Pract 12:51-3. 2003
  4. ncbi Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation
    Arrigo F G Cicero
    Atherosclerosis and Metabolic Diseases Study Centre G Descovich, Clinical Medicine and Applied Biotechnology, Dept D Campanacci, S Orsola Malpighi University Hospital, Via Massarenti, 9, 40138 Bologna, Italy
    Eur J Nutr 43:319-22. 2004
  5. doi Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients
    Arrigo F G Cicero
    Hypertension Research Unit, Sant Orsola Malpighi Hospital, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy
    Fundam Clin Pharmacol 23:583-8. 2009
  6. ncbi Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study
    Arrigo F G Cicero
    1 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
    Metab Syndr Relat Disord 11:412-6. 2013
  7. doi Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice
    Arrigo F G Cicero
    Department of Internal Medicine, Aging and Kidney diseases, S Orsola Malpighi University Hospital, University of Bologna, Pad 2 Via Albertoni 15, Bologna, Italy
    Clin Exp Hypertens 34:113-7. 2012
  8. doi Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome
    Arrigo F G Cicero
    Department of Internal Medicine, Aging and Kidney diseases, University of Bologna, Bologna, Italy
    Eur J Cardiovasc Prev Rehabil 16:698-704. 2009
  9. doi Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects
    Arrigo F G Cicero
    Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy
    Nutr Res 33:622-8. 2013
  10. doi Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers
    Arrigo F G Cicero
    Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Bologna, Italy
    J Altern Complement Med 19:582-7. 2013

Detail Information

Publications47

  1. ncbi Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study
    Arrigo F G Cicero
    Department of Internal Medicine and Applied Biotechnology, Atherosclerosis and Metabolic Diseases Study Centre G Descovich, University of Bologna, S Orsola Malpighi University Hospital Via Massarenti, 9 40138 Bologna, Italy
    Complement Ther Med 13:273-8. 2005
    ....
  2. ncbi Effect of oral chronic isoflavones supplementation on male rat sexual performances and sexual hormone plasma levels
    Arrigo F G Cicero
    Biomedical Sciences Department, Pharmacology Section, University of Modena and Reggio nell emilia, Modena, Italy
    Phytother Res 18:849-52. 2004
    ..No significant difference has been observed as regards FSH, progesterone, androstenedione plasma levels, either between groups or between baseline and study end. Slight differences were found regards LH and testosterone plasma level...
  3. ncbi Asymptomatic massive hypertriglyceridemia in an octogenarian
    Arrigo F G Cicero
    Atherosclerosis and Metabolism Diseases Study Centre GC Descovich, Clinical Medicine and Applied Biotechnology Department D Campanacci, University of Bologna, Italy
    Med Princ Pract 12:51-3. 2003
    ..To report the case of an 85-year-old man with asymptomatic massive hypertriglyceridemia (MHTG)...
  4. ncbi Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation
    Arrigo F G Cicero
    Atherosclerosis and Metabolic Diseases Study Centre G Descovich, Clinical Medicine and Applied Biotechnology, Dept D Campanacci, S Orsola Malpighi University Hospital, Via Massarenti, 9, 40138 Bologna, Italy
    Eur J Nutr 43:319-22. 2004
    ..High doses of soy protein are able to decrease plasma cholesterolemia significantly, but they unbalance daily protein intake and strongly modify nutritional habits in patients...
  5. doi Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients
    Arrigo F G Cicero
    Hypertension Research Unit, Sant Orsola Malpighi Hospital, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy
    Fundam Clin Pharmacol 23:583-8. 2009
    ....
  6. ncbi Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study
    Arrigo F G Cicero
    1 Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
    Metab Syndr Relat Disord 11:412-6. 2013
    ..17, 95% CI 1.15-1.18). Conclusion: HSI and LAP differently predict the 4-year incidence of metabolic syndrome. In women, both indexes can be considered significant predictors, whereas in men only LAP can be considered predictive. ..
  7. doi Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice
    Arrigo F G Cicero
    Department of Internal Medicine, Aging and Kidney diseases, S Orsola Malpighi University Hospital, University of Bologna, Pad 2 Via Albertoni 15, Bologna, Italy
    Clin Exp Hypertens 34:113-7. 2012
    ..Moreover, the association of lercanidipine with renin-angiotensin system blockers is also associated with significant improvements in triglycerides and fasting plasma glucose...
  8. doi Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndrome
    Arrigo F G Cicero
    Department of Internal Medicine, Aging and Kidney diseases, University of Bologna, Bologna, Italy
    Eur J Cardiovasc Prev Rehabil 16:698-704. 2009
    ..It is not known whether serum level of vascular remodelling parameters, such as matrix metalloproteinases could be modulated by physical activity and whether the eventual change could be influenced by metabolic syndrome (MS) diagnosis...
  9. doi Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects
    Arrigo F G Cicero
    Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy
    Nutr Res 33:622-8. 2013
    ..These results have to be confirmed in larger patient samples and longer studies. ..
  10. doi Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers
    Arrigo F G Cicero
    Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Bologna, Italy
    J Altern Complement Med 19:582-7. 2013
    ....
  11. ncbi Cerebrovascular disease in Italy and Europe: it is necessary to prevent a 'pandemia'
    Antonio Gaddi
    Atherosclerosis and Dysmetabolic Disease Study Centre G Descovich, University of Bologna, Bologna, Italy
    Gerontology 49:69-79. 2003
    ..The aim of this review is to resume the actual knowledge about the epidemiology of cerebrovascular disease in Italy and Europe, and about the means available to prevent this phenomenon...
  12. doi Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample: the Brisighella Heart Study
    Arrigo F G Cicero
    Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Bologna, Italy
    J Hypertens 30:492-6. 2012
    ..The objective is to evaluate the relationship between cholesterolemia, serum apolipoprotein B (apoB) level and blood pressure in a large sample of general population...
  13. ncbi Persistence on treatment and blood pressure control with different first-line antihypertensive treatments: a prospective evaluation
    Maria Grazia Prandin
    D Campanacci Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
    Clin Exp Hypertens 29:553-62. 2007
    ..46.6%). Systolic and diastolic BP decreased more in patients treated with ARBs (-11.2/-5.8 mmHg), ACE inhibitors (-10.5/-5.1 mmHg), and CCBs (-8.5/-4.6 mmHg) when compared to beta-blockers (-4.0/-2.3 mmHg) and diuretics (-2.3/-2.1 mmHg)...
  14. doi Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort
    Arrigo F G Cicero
    Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Bologna, Italy
    Obes Facts 5:319-26. 2012
    ..Our aim was to evaluate the relation of the sex hormone pattern and the serum level of the main adipokines with metabolic syndrome (MS) and its components in a cohort of pharmacologically untreated adult elderly subjects...
  15. ncbi Effects of a new soy/beta-sitosterol supplement on plasma lipids in moderately hypercholesterolemic subjects
    Arrigo F G Cicero
    Atherosclerosis and Dysmetabolic Disease Study Center G Descovich, Clinical Medicine and Applied Biotechnologies D Campanacci, University of Bologna, Italy
    J Am Diet Assoc 102:1807-11. 2002
    ..According to this recommends, low doses of soy protein added in b-sitosterol seems to be a practical and safe alternative for patients seeking modest reductions in LDL-C (< 15%)...
  16. pmc Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials
    Arrigo F G Cicero
    Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Bologna, Italy
    Am J Hypertens 26:442-9. 2013
    ..This decrease is convincingly shown in subjects of Asian origin, but less consistent results have been obtained in European populations...
  17. doi The role of irbesartan in the treatment of patients with hypertension: a comprehensive and practical review
    Claudio Borghi
    Department of Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy
    High Blood Press Cardiovasc Prev 19:19-31. 2012
    ....
  18. ncbi Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure
    Claudio Borghi
    Department of Internal Medicine, University of Bologna, Bologna, Italy
    J Hypertens 25:2051-7. 2007
    ..To investigate the possible interactions between serum cholesterol levels and the renin-angiotensin system on the development of stable hypertension in subjects with high-normal blood pressure (BP)...
  19. ncbi Leisure-time physical activity and cardiovascular disease mortality: the Brisighella Heart Study
    Arrigo F G Cicero
    Department of Internal Medicine, Aging and Kidney diseases, University of Bologna, Bologna, Italy
    J Cardiovasc Med (Hagerstown) 13:559-64. 2012
    ....
  20. pmc Psychosocial factors and metabolic parameters: is there any association in elderly people? The Massa Lombarda Project
    Marilisa Bove
    GC Descovich Atherosclerosis and Metabolic Diseases Research Unit, Internal Medicine, Department of Aging and Kidney Diseases, Sant Orsola Malpighi Hospital, University of Bologna, Via Massarenti, 9 40138 Bologna, Italy
    Aging Ment Health 14:801-6. 2010
    ..The aim of our research is to discover and analyse a possible relationship between two psychosocial disorders (depression and perceived mental stress) and traditional cardiovascular risk markers...
  21. doi Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial
    Arrigo F G Cicero
    Hypertension Research Center, Department of Internal Medicine, Aging and Kidney Disease, University of Bologna, Bologna, Italy
    Hypertens Res 34:1035-40. 2011
    ..No effect was observed on parameters related to fluid dynamics or vascular resistance. LTPs positively influenced the office SBP, PWV, SV, SV index, ACI and VI in patients with high-normal BP or first-degree hypertension...
  22. ncbi Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation
    Arrigo F G Cicero
    G Descovich Atherosclerosis and Dysmetabolic Disease Research Center, D Campanacci Clinical Medicine and Applied Biotechnology Department, University of Bologna, Bologna, Italy
    Arzneimittelforschung 57:26-30. 2007
    ....
  23. ncbi Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments
    Arrigo F G Cicero
    Medicine and Surgery Sciences Department, University of Bologna, S Orsola Malpighi University Hospital, Via Albertoni, 15, 40138 Bologna, Italy Electronic address
    Atherosclerosis 235:81-3. 2014
    ..to evaluate the main factors associated with long-term persistence in fully paid lipid-lowering treatment...
  24. doi Population health needs assessment and healthcare services use in a 3 years follow-up on administrative and clinical data: results from the Brisighella Heart Study
    Arrigo F G Cicero
    Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
    High Blood Press Cardiovasc Prev 21:45-51. 2014
    ....
  25. doi Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals
    Arrigo F G Cicero
    Medical and Surgical Science Department, University of Bologna, Via Albertoni 15 Pad 2, 40138, Bologna, Italy
    Curr Hypertens Rep 15:260-7. 2013
    ....
  26. ncbi Changes in LDL fatty acid composition as a response to olive oil treatment are inversely related to lipid oxidative damage: The EUROLIVE study
    Arrigo F G Cicero
    GC Descovich Atherosclerosis and Metabolic Disease Research Unit, Internal Medicine, Aging and Kidney Diseases Dept, University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy
    J Am Coll Nutr 27:314-20. 2008
    ..The aim of our study was to assess the changes in the fatty acid composition of low density lipoproteins (LDL) after sustained consumption of olive oil at real-life doses (25 mL/day) and their relationship with lipid oxidative damage...
  27. ncbi Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population
    Arrigo F G Cicero
    Atherosclerosis Study Center G Descovich, Clinical Medicine and Applied Biotechnologies, Dept D Campanacci, University of Bologna, Italy
    J Cardiovasc Risk 10:149-51. 2003
    ..Serum lipoprotein (a) [Lp(a)] is a lipidic parameter, strictly under genetic control. Lp(a) levels vary in different dyslipidaemias according to the underlying disease...
  28. doi Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study
    Arrigo F G Cicero
    aInternal medicine, Aging and Kidney Disease Department, University of Bologna, Bologna bDepartment of Cardiology, Istituto Auxologico Italiano, Milan, Italy
    J Hypertens 32:57-64. 2014
    ..The aim of our study was to verify in a large well characterized population sample the relationship between SUA values, hypertension, arterial stiffness and subclinical atherosclerosis...
  29. ncbi Zofenopril and ramipril and acetylsalicylic acid in postmyocardial infarction patients with left ventricular systolic dysfunction: a retrospective analysis in hypertensive patients of the SMILE-4 study
    Claudio Borghi
    Unit of Internal Medicine, Policlinico S Orsola, University of Bologna, Bologna
    J Hypertens 31:1256-64. 2013
    ....
  30. doi Hypertension: management perspectives
    Claudio Borghi
    University of Bologna, Internal Medicine, Aging and Kidney Diseases Department, Bologna, Italy
    Expert Opin Pharmacother 13:1999-2003. 2012
    ..So what are the possible future perspectives for high BP management?..
  31. doi Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects
    Arrigo F G Cicero
    Atherosclerosis and Metabolic disease Research Unit, Internal Medicine, Aging and Kidney Diseases Department, University of Bologna, S Orsola Malpighi Hospital, Via Albertoni, 15, 40138 Bologna, Italy
    Expert Opin Drug Saf 11:753-66. 2012
    ..Lifestyle interventions, including dietary supplementation with natural compounds possessing known lipid-lowering effects, are strongly supported by the international guidelines for cardiovascular disease prevention...
  32. ncbi Cerebrovascular disease in Italy and Europe: it is necessary to prevent a 'pandemia'
    Antonio Gaddi
    Atherosclerosis and Dysmetabolic Disease Study Centre G Descovich, University of Bologna, Italy
    J Cardiovasc Risk 9:143-5. 2002
    ..It is plausible that the application of a suitable early prevention of the cerebrovascular pathology could bring to a more late slatentisation and less serious demonstrations of Alzheimer's disease, when this is destined to develop...
  33. ncbi Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial
    Arrigo F G Cicero
    GC Descovich Atherosclerosis Research Centre, D Campanacci Clinical Medicine and Applied Biotechnology Dept, University of Bologna, Italy
    Clin Exp Hypertens 29:383-94. 2007
    ..In our study, six-month supplementation with psyllium fiber, but not with guar fiber nor standard diet, appears to significantly reduce both SBP and DBP in hypertensive overweight subjects...
  34. ncbi Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence
    Arrigo F G Cicero
    S Orsola Malpighi University Hospital, Medical and Surgical Sciences Department, Internal Medicine Unit, Pad 2, Via Albertoni 15, 40138 Bologna, Italy 39 3498558017 39 0516826125
    Expert Opin Biol Ther 14:863-8. 2014
    ..Moreover, a large number of subjects cannot tolerate statins or full doses of these drugs. Thus, there is a need for additional effective LDL-C reducing agents...
  35. ncbi Combined lipoxygenase/cyclo-oxygenase inhibition in the elderly: the example of licofelone
    Arrigo F G Cicero
    Clinical Medicine and Applied Biotechnology Department D Campanacci, Atherosclerosis and Dysmetabolic Diseases Study Center G C Descovich, University of Bologna, Bologna, Italy
    Drugs Aging 22:393-403. 2005
    ..Preliminary data with this drug seem promising, but further well designed clinical trials of this agent in the elderly will be necessary before a final evaluation is possible...
  36. pmc Fixed combination of zofenopril plus hydrochlorothiazide in the management of hypertension: a review of available data
    Claudio Borghi
    Hypertension Research Center, D Campanacci Clinical Medicine and Applied Biotechnology Department, Alma Mater Studiorum, University of Bologna, Italy
    Vasc Health Risk Manag 2:341-9. 2006
    ....
  37. ncbi Uricaemia and ejection fraction in elderly heart failure outpatients
    Claudio Borghi
    Medical and Surgical Sciences Department, University of Bologna, Bologna, Italy
    Eur J Clin Invest 44:573-8. 2014
    ..The aim of our study was to test the relationship between SUA and left ventricular ejection fraction (EF%) in a cohort of elderly hypertensive outpatients with chronic HF...
  38. doi Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice
    Claudio Borghi
    Internal Medicine, Aging and Kidney Disease Department, University of Bologna, Italy
    Ann Med 46:97-102. 2014
    ..We aimed at evaluating the association between low-density lipoprotein cholesterol (LDL-C) level and incidence of new onset of hypertension in a large population sample...
  39. pmc Application of polyunsaturated fatty acids in internal medicine: beyond the established cardiovascular effects
    Arrigo F G Cicero
    Medical and Surgical Sciences Department, University of Bologna, Italy
    Arch Med Sci 8:784-93. 2012
    ....
  40. pmc Adipokines and sexual hormones associated with the components of the metabolic syndrome in pharmacologically untreated subjects: data from the brisighella heart study
    Arrigo F G Cicero
    Department of Internal Medicine, Aging and Kidney Disease Department, University of Bologna, 40138 Bologna, Italy
    Int J Endocrinol 2011:724816. 2011
    ..87, 95% CI 0.79-0.95). In conclusion, in a sample of pharmacologically untreated subjects, leptin/adiponectin ratio seems to be the factor more strongly associated to MS and its components...
  41. ncbi Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Endothelium 14:45-51. 2007
    ..MMP-9, TIMP-1, and TIMP-2 plasma levels were increased in diabetic patients with ACSs, which may reflect abnormal extracellular matrix metabolism in diabetes during acute event...
  42. ncbi Hypercholesterolemia underdiagnosis and undertreatment in psychiatric patients in Italy
    Arrigo F G Cicero
    Eur J Epidemiol 18:373-4. 2003
  43. ncbi The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 25:1429-39. 2003
    ..A previous study has demonstrated that L-carnitine reduces plasma lipoprotein(a) (Lp[a]) levels in patients with hypercholesterolemia...
  44. ncbi Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial
    Giuseppe Derosa
    Department o f Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Clin Ther 29:602-10. 2007
    ..The autonomic nervous system plays an important part in the homeostasis of blood pressure (BP), and sympathetic overactivity may contribute to metabolic conditions such as glycemic intolerance or insulin resistance...
  45. ncbi Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, doubl
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 26:1228-36. 2004
    ..Angiotensin receptor blockers (ARBs) provide effective blood pressure control. Whereas none of the ARBs appear to affect glucose homeostasis, some ARBs have been associated with a decrease in cholesterolemia...
  46. ncbi A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, P le C Golgi, 2 27100 Pavia, Italy
    Diabetes Res Clin Pract 69:5-13. 2005
    ..To compare the effects of glimepiride plus pioglitazone or plus rosiglitazone in diabetic patients with the metabolic syndrome on coagulation and fibrinolysis parameters...
  47. ncbi [Cardiovascular risk factors in severely ill psychiatric patients]
    Arrigo F G Cicero
    Centro per lo studio dell aterosclerosi e delle malattie dismetaboliche GC Descovichi, Ospedale Sant Orsola Malpighi Bologna
    Epidemiol Prev 27:40-3. 2003
    ..Thus, we find unethical do not treat hypertension, dyslipidemia and diabetes in severe psychiatric patients...